KROS
KEROS THERAP (KROS)
NASDAQ
$10.56-$0.54 (-4.86%)
Price as of Jul 14, 2026 4:10 PM EDT
  • $219.7M
    Market Cap
  • -23.82%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 59
Valuation
KROS
vs History
vs S&P 500
Profitability
0
Growth
1
Low Earnings Volatility
0

Momentum Score

Score: 45
Valuation
KROS
vs History
vs S&P 500
3-Month Momentum
-20.88%
12-Month Momentum
-31.23%
3-Month Risk Adjusted Momentum
-92.96%
12-Month Risk Adjusted Momentum
-67.00%

True Yield

N/A
Valuation
KROS
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
4.41%
Net Debt Paydown Yield
N/A

Financial Health Score

Score: 100
Valuation
KROS
vs History
vs S&P 500
Ohlson's O-Score
13